Prevalence of Irritable Bowel Syndrome-like Symptoms Using Rome IV Criteria in Patients with Inactive Inflammatory Bowel Disease and Relation with Quality of Life

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2020 May 9

PMID 32384473

Citations 8

Authors

Muhammet Ozer

Goksel Bengi

Rumeysa Colak

Ozan Cengiz

Hale Akpinar

Affiliations

Soon will be listed here.

Abstract

Irritable bowel syndrome (IBS)-like symptoms tend to be common in inflammatory bowel disease (IBD) patients even during the long-standing remission phase, and quality of life (QOL) seem to reduce in IBD patients with such symptoms. Thus, the aim of this study was to define the prevalence of IBS-like symptoms in inactive IBD patients using Rome IV criteria and evaluate the effect of IBS-like symptoms on QOL.Total 137 patients with IBD (56 with ulcerative colitis (UC) and 81 with Crohn disease (CD), who had been in long-standing remission according to the clinical scoring system and 123 control participants were included. These patients completed questionnaires to evaluate IBS-like symptoms according to Rome IV criteria, and the impact of these symptoms on the QOL of inactive IBD patients was compared with and without IBS-like symptoms according to disease-specific inflammatory bowel disease questionnaire (IBDQ).Depending on our research, IBS-like symptoms were found in 32% (18/56) of patients with inactive UC, 35% (29/81) of patients with inactive CD, and 13.8% (17/123) of control participants (P < .001). The QOL seemed to be significantly lower in both inactive UC and CD patients with IBS-like symptoms than in those without such symptoms (P < .001).In conclusion, we defined that the prevalence of IBS-like symptoms in IBD patients in remission is 2 to 3 times higher than that in healthy control participants, and significantly lower IBDQ scores showed QOL was reduced in inactive IBD patients with IBS-like symptoms as compared with patients without IBS-like symptoms.

Citing Articles

IBS and IBD-One Letter, Much Pain, Few Treatments.

Scott J, Taleban S Dig Dis Sci. 2025; .

PMID: 39953184 DOI: 10.1007/s10620-025-08892-5.

Crohn's disease, irritable bowel syndrome, and chronic fatigue: the importance of communication and symptom management-a case report.

Haedrich J, Huber R J Med Case Rep. 2025; 19(1):9.

PMID: 39789666 PMC: 11721286. DOI: 10.1186/s13256-024-05010-3.

Evolution, adaptation, and new applications of the FODMAP diet.

OBrien L, Kasti A, Halmos E, Tuck C, Varney J JGH Open. 2024; 8(5):e13066.

PMID: 38770353 PMC: 11103764. DOI: 10.1002/jgh3.13066.

Latent profiles of fatigue in inflammatory bowel disease.

Barnes A, Toson B, Bryant R, Mukherjee S, Andrews J, Spizzo P BMC Gastroenterol. 2024; 24(1):148.

PMID: 38689277 PMC: 11061964. DOI: 10.1186/s12876-024-03239-2.

Predictors of irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease.

Ahmed M, Pu A, Jencks K, Bishu S, Higgins P, Chey W Neurogastroenterol Motil. 2024; 36(6):e14809.

PMID: 38651743 PMC: 11806413. DOI: 10.1111/nmo.14809.

References

Mawe G, Collins S, Shea-Donohue T . Changes in enteric neural circuitry and smooth muscle in the inflamed and infected gut. Neurogastroenterol Motil. 2004; 16 Suppl 1:133-6. DOI: 10.1111/j.1743-3150.2004.00489.x. View

Vivinus-Nebot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R . Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 2013; 63(5):744-52. DOI: 10.1136/gutjnl-2012-304066. View

Chaudhary N, TRUELOVE S . The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med. 1962; 31:307-22. View

Jonefjall B, Strid H, Ohman L, Svedlund J, Bergstedt A, Simren M . Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission. Neurogastroenterol Motil. 2013; 25(9):756-e578. DOI: 10.1111/nmo.12163. View

Ansari R, Attari F, Razjouyan H, Etemadi A, Amjadi H, Merat S . Ulcerative colitis and irritable bowel syndrome: relationships with quality of life. Eur J Gastroenterol Hepatol. 2007; 20(1):46-50. DOI: 10.1097/MEG.0b013e3282f16a62. View

Farrokhyar F, Marshall J, Easterbrook B, Irvine E . Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2005; 12(1):38-46. DOI: 10.1097/01.mib.0000195391.49762.89. View

Russel M, Pastoor C, Brandon S, Rijken J, Engels L, van der Heijde D . Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion. 1997; 58(3):282-8. DOI: 10.1159/000201455. View

Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson E . Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002; 97(2):389-96. DOI: 10.1111/j.1572-0241.2002.05475.x. View

Collins S, McHugh K, Jacobson K, Khan I, Riddell R, Murase K . Previous inflammation alters the response of the rat colon to stress. Gastroenterology. 1996; 111(6):1509-15. DOI: 10.1016/s0016-5085(96)70012-4. View

10.

Thompson W, Heaton K, Smyth G, Smyth C . Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut. 1999; 46(1):78-82. PMC: 1727778. DOI: 10.1136/gut.46.1.78. View

11.

Isgar B, Harman M, Kaye M, Whorwell P . Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983; 24(3):190-2. PMC: 1419934. DOI: 10.1136/gut.24.3.190. View

12.

Schmulson M, Drossman D . What Is New in Rome IV. J Neurogastroenterol Motil. 2017; 23(2):151-163. PMC: 5383110. DOI: 10.5056/jnm16214. View

13.

Hjortswang H, Strom M, Almer S . Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol. 1998; 93(11):2203-11. DOI: 10.1111/j.1572-0241.1998.00537.x. View

14.

Agreus L, Svardsudd K, Nyren O, Tibblin G . Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995; 109(3):671-80. DOI: 10.1016/0016-5085(95)90373-9. View

15.

Neal K, Hebden J, Spiller R . Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ. 1997; 314(7083):779-82. PMC: 2126206. DOI: 10.1136/bmj.314.7083.779. View

16.

Tomita T, Kato Y, Takimoto M, Yamasaki T, Kondo T, Kono T . Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease. J Neurogastroenterol Motil. 2016; 22(4):661-669. PMC: 5056576. DOI: 10.5056/jnm15160. View

17.

Minderhoud I, Oldenburg B, Wismeijer J, van Berge Henegouwen G, Smout A . IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004; 49(3):469-74. DOI: 10.1023/b:ddas.0000020506.84248.f9. View

18.

Mitchell C, Drossman D . Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987; 92(5 Pt 1):1282-4. DOI: 10.1016/s0016-5085(87)91099-7. View

19.

Guyatt G, Mitchell A, Irvine E, Singer J, Williams N, Goodacre R . A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989; 96(3):804-10. View

20.

Pace F, MOLTENI P, Bollani S, Sarzi-Puttini P, Stockbrugger R, Bianchi Porro G . Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol. 2003; 38(10):1031-8. DOI: 10.1080/00365520310004524. View